Extracellular matrix and growth factors in the pathogenesis of some craniofacial malformations

European Journal of Histochemistry

Volumn 51, Issue SUPPL.1, 2007, Pages 105-116

  Carinci, Paolo ^a   Becchetti, E ^b   Baroni, T ^b   Carinci, F ^c   Pezzetti, F ^a   Stabellini, G ^d   Locci, P ^b   Scapoli, L ^a   Tognon, M ^c   Volinia, S ^c   Bodo, M ^b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

^c UNIVERSITY OF FERRARA   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

Author keywords

Cleft lip; Cleft palate; Craniosynostosis; Extracellular matrix; Growth factors

Indexed keywords

GROWTH PROMOTOR;

CRANIOFACIAL MALFORMATION; EXTRACELLULAR MATRIX; HUMAN; METABOLISM; PATHOLOGY; REVIEW;

CRANIOFACIAL ABNORMALITIES; EXTRACELLULAR MATRIX; GROWTH SUBSTANCES; HUMANS;

EID: 35148824214     PISSN: 1121760X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (49)

1. Baroni T, Lilli C, Marinucci L, Bellocchio S, Pezzetti F, Carinci F, et al. Crouzon's syndrome: differential in vitro secretion of bFGF, TGFbeta I isoforms and extracellular matrix macromolecules in patients with FGFR2 gene mutation. Cytokine 2002;19:94-101.
2. Baroni T, Carinci P, Bellucci C, Lilli C, Becchetti E, Carinci F, et al. Cross-talk between interleukin-6 and transforming growth factorbeta3 regulates extracellular matrix production by human fibroblasts from subjects with non-syndromic cleft lip and palate. J Periodontol 2003; 74:1447-53.
3. Baroni T, Carinci P, Lilli C, Bellucci C, Aisa MC, Scapoli L, et al. P253R fibroblast growth factor receptor-2 mutation induces RUNX2 transcript variants and calvarial osteoblast differentiation. J Cell Physiol 2005; 202:524-35.
4. Baroni T, Bellucci C, Lilli C, Pezzetti F, Carinci F, Becchetti E, et al. Retinoic acid, GABA-ergic and TGF-beta signaling systems are involved in human cleft palate fibroblast phenotype. Mol Med 2006;12:237-45.
5. Bodo M, Carinci F, Baroni T, Becchetti E, Giammarioli M, Bellucci C, et al. Effects of interleukins on Crouzon fibroblast phenotype in vitro. Release of cytokines and IL-6 mRNA expression. Cytokine 1996; 8:772-83
6. Bodo M, Carinci F, Baroni T, Giammarioli M, Bellucci C, Bosi G, et al. Apert's syndrome: differential in vitro production of matrix macromolecules and its regulation by interleukins. Eur J Clin Invest 1997; 27:36-42.
7. Bodo M, Carinci F, Baroni T, Becchetti E, Bellucci C, Giammarioli M, et al. Interleukin pattern of Apert fibroblasts in vitro. Eur J Cell Biol 1998a;75:383-8.
8. Bodo M, Carinci P, Baroni T, Bellucci C, Giammarioli M, Pezzetti F, et al. Role of growth factors on extracellular matrix production by chick embryo fibroblasts in vitro. Antagonist effect of TGF-c through the control of IL-1 and IL-1Ra secretion. Cytokine 1998b;10: 353-60.
9. Bodo M, Baroni T, Carinci F, Becchetti E, Bellucci C, Conte C, et al. A regulatory role of fibroblast growth factor in the expression of decorin, biglycan, betaglycan and syndecan in osteoblasts from patients with Crouzon's syndrome. Eur J Cell Biol. 1999a;78:323-30.
10. Bodo M, Baroni T, Carinci F, Becchetti E, Bellucci C, Pezzetti F, et al. TGFbeta isoforms and decorin gene expression are modified in fibroblasts obtained from non-syndromic cleft lip and palate subjects. J Dent Res 1999b;78:1783-90.
11. Bodo M, Lilli C, Aisa MC, Scapoli L, Bellucci C, Rinaldi E, et al. Basic fibroblast growth factor: Effects on matrix remodeling, receptor expression, and transduction pathway in human periosteal fibroblasts with fgfr2 gene mutation. J Interferon Cytokine Res 2002a; 22: 621-30.
12. Canalis E, McCarthy TL, Centrella M. The role of growth factors in skeletal remodeling. Endocrinol Metab Clin North Am 1989; 18:903-18.
13. Carinci F, Pezzetti F, Scapoli L, Padula E, Baciliero U, Curioni C, et al. Nonsyndromic cleft lip and palate: evidence of linkage to a microsatellite marker on 6p23. Am J Hum Genet 1995;56:337-9.
14. Carinci F, Bodo M, Tosi L, Francioso F, Evangelisti R, Pezzetti F, et al. Expression profiles of craniosynostosis-derived fibroblasts. Mol Med. 2002; 8:638-44.
15. Carinci F, Pezzetti F, Scapoli L, Martinelli M, Avantaggiato A, Carinci P, et al. Recent developments in orofacial cleft genetics. J Craniofac Surg. 2003;14:130-43.
16. Carinci F, Pezzetti F, Locci P, Becchetti E, Carls F, Avantaggiato A, et al. Apert and Crouzon syndromes: clinical findings, genes and extracellular matrix. J Craniofac Surg 2005;16:361-8.
17. Cohen MM Jr, MacLean RE. Craniosynostosis: Diagnosis, evaluation, and management. 2nd edn. New York: Oxford University Press, 2000.
18. Delezoide AL, Benoist-Lasselin C, Legeai-Mallet L, Le Merrer M, Munnich A, Vekemans M, et al. Spatio-temporal expression of FGFR 1, 2, and 3 genes during human embryo-fetal ossification. Mech Dev 1998; 77:19-30.
19. Ducy P. Cbfa1: A molecular switch in osteoblast biology. Dev Dyn 2000; 219: 461-71.
20. Frenz DA, Liu W, Williams JD, Hatcher V, Galinovic-Schwartz V, Flanders KC, et al. Induction of chondrogenesis: requirement for synergistic interaction of basic fibroblast growth factor and transforming growth factor-beta. Development 1994;120:415-24.
21. Ibrahimi OA, Zhang F, Eliseenkova AV, Itoh N, Linhardt RJ, Mohammadi M. Biochemical analysis of pathogenic ligand-dependent FGFR2 mutations suggests distinct pathophysiological mechanisms for craniofacial and limb abnormalities. Hum Mol Genet 2004, 13: 2313-24.
22. Janssens K, ten Dijke P, Janssens S, Van Hul W. Transforming growth factor-beta1 to the bone. Endocr Rev 2005;26:743-74.
23. Kaartinen V, Voncken JW, Shuler C, Warburton D, Bu D, Heisterkamp N. Abnormal lung development and cleft palate in mice lacking TGF-beta 3 indicates defects of epithelial-mesenchymal interaction. Nat Genet 1995; 11: 415-21.
24. Kan SH, Elanko N, Johnson D, Cornejo-Roldan L, Cook J, Reich EW, et al. Genomic screening of fibroblast growth-factor receptor 2 reveals a wide spectrum of mutations in patients with syndromic craniosynostosis. Am J Hum Genet 2002; 70:472-486
25. Kreiborg S, Marsh JL, Cohen MM Jr, Liversage M, Pedersen H, Skovby F, et al. Comparative three-dimensional analysis of CT-scans of the calvaria and cranial base in Apert and Crouzon syndromes. J Craniomaxillofac Surg 1993; 21:181-88.
26. Lidral AC, Romitti PA, Basart AM, Doetschman T, Leysens NJ, Daack-Hirsch S, Semina EV, Johnson LR, Machida J, Burds A, Parnell TJ, Rubenstein JL, Murray JC. Association of MSX1 and TGFB3 with nonsyndromic clefting in humans. Am J Hum Genet 1998; 63: 557-68.
27. Locci P, Baroni T, Pezzetti F, Lilli C, Marinucci L, Martinese D, et al. Differential in vitro phenotype pattern, transforming growth factorbeta(1) activity and mRNA expression of transforming growth factor-beta(1) in Apert osteoblasts. Cell Tissue Res 1999; 297:475-83.
28. Malemud CJ. Matrix metalloproteinases (MMPs) in health and disease: an overview. Front Biosci 2006;11:1696-701.
29. Massaguè J. Identification of receptors for type-beta transforming growth factor. Methods Enzymol. 1987; 146:174-95.
30. Morriss-Kay GM, Wilkie AO. Growth of the normal skull vault and its alteration in craniosynostosis: insights from human genetics and experimental studies. J Anat 2005; 207:637-53.
31. Moursi AM, Damsky CH, Lull J, Zimmerman D, Doty SB, Aota S, et al. Fibronectin regulates calvarial osteoblast differentiation. J Cell Sci 1996;109:1369-80.
32. Naski MC, Ornitz DM. FGF signaling in skeletal development. Front Biosci 1998; 3: 781-94.
33. Pezzetti F, Scapoli L, Martinelli M, Carinci F, Bodo M, Carinci P, et al. A locus in 2p13-p14 (OFC2), in addition to that mapped in 6p23, is involved in nonsyndromic familial orofacial cleft malformation. Genomics 1998;50:299-305.
34. Qiu C, Ferguson M. The distribution of PDGFs and PDGFreceptors during murine secondary palate development. J Anat 1995;186:17-29.
35. Robertson SC, Meyer AN, Hart KC, Galvin BD, Webster MK, Donoghue DJ. Activating mutations in the extracellular domain of the fibroblast growth factor receptor 2 function by disruption of the disulfide bond in the third immunoglobulin-like domain. Proc Natl Acad Sci USA 1998;95: 4567-72.
36. Roodman GD, Kurihara N, Ohsaki Y. Interleukin-6: Apotential autocrine/paracrine factor in Paget's disease of bone. J Clin Invest 1992;89:46-52.
37. Scapoli L, Pezzetti F, Carinci F, Martinelli M, Carinci P, Tognon M. Evidence of linkage to 6p23 and genetic heterogeneity in nonsyndromic cleft lip with or without cleft palate. Genomics 1997; 15;43:216-20.
38. Scapoli L, Pezzetti F, Carinci F, Martinelli M, Carinci P, Tognon M. Lack of linkage disequilibrium between transforming growth factor alpha Taq I polymorphism and cleft lip with or without cleft palate in families from Northeastern Italy. Am J Med Genet 1998;75:203-6.
39. Scapoli L, Martinelli M, Pezzetti F, Carinci F, Bodo M, Tognon M, et al. Linkage disequilibrium between GABRB3 gene and nonsyndromic familial cleft lip with or without cleft palate. Hum Genet 2002;110:15-20.
40. Schluns KS, Cook JE, Le PT. TGF-beta differentially modulates epidermal growth factor-mediated increases in leukemia-inhibitory factor, IL-6, IL-1 alpha, and IL-1 beta in human thymic epithelial cells. J Immunol 1997;2704-11.
41. Stein JD, Hecht JT, Blanton SH. Exclusion of retinoic acid receptor and a cartilage matrix protein in non-syndromic CL(P) families. J Med Genet 1995;32: 78.
42. Szebenyi G, Fallon JF. Fibroblast growth factors as multifunctional signaling factors. Int Rev Cytol 1999;185:45-106.
43. Thorogood P. The developmental specification of the vertebrate skull. Development 1988;103:141-153.
44. Yayon A, Klagsbrun M. Autocrine transformation by a chimeric signalpeptide-basic fibroblast growth factor: Reversal by suramin. Proc Natl Acad Sci USA 1990; 87: 5346-50.
45. Young DL, Schneider RA, Hu D, Helms JA. Genetic and teratogenic approaches to craniofacial development. Crit Rev Oral Biol Med 2000; 11:304-17.
46. Wilkie AO. Bad bones, absent smell, selfish testes: the pleiotropic consequences of human FGF receptor mutations. Cytokine Growth Factor Rev 2005; 16:187-203.
47. Wilkie AO, Bochukova EG, Hansen RM, Taylor IB, Rannan-Eliya SV, Byren JC, et al. Clinical dividends from the molecular genetic diagnosis of craniosynostosis. Am J Med Genet A 2006 (Epub ahead of print)
48. Xu T, Bianco P, Fisher LW, Longenecker G, Smith E, Goldstein S, et al. Targeted disruption of the biglycan gene leads to an osteoporosislike phenotype in mice. Nat Genet 1998;20:78-82.
49. Yu K, Herr AB, Waksman G, Ornitz DM. Loss of fibroblast growth factor receptor 2 ligand-binding specificity in Apert syndrome. Proc Natl Acad Sci USA 2000; 97:14536-41.